Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | bexaroten för lokalt bruk | false | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Bexarotene (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | har täljarvärde för koncentrationsstyrka | tio | false | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Bexarotene (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Bexarotene (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing only bexarotene in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
This concept is not in any reference sets